Type I Collagen Synthesis Marker Procollagen I N-Terminal Peptide (PINP) in Prostate Cancer Patients Undergoing Intermittent Androgen Suppression

Intermittent androgen suppression (IAS) therapy for prostate cancer patients attempts to maintain the hormone dependence of the tumor cells by cycles alternating between androgen suppression (AS) and treatment cessation till a certain prostate-specific antigen (PSA) threshold is reached. Side effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Gerhard, Olszewski-Hamilton, Ulrike, Theyer, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759212/
https://www.ncbi.nlm.nih.gov/pubmed/24212969
http://dx.doi.org/10.3390/cancers3033601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759212/
https://www.ncbi.nlm.nih.gov/pubmed/24212969
http://dx.doi.org/10.3390/cancers3033601

Ejemplares similares